Skip to content

SAVICELL Corp

company.status.inactive

CIK 1498380fmd_0RXZRSH7TRZ12YYE5G9RWNDPHMManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2019, 39 periods

Latest annual · FY2013

Millions
Operating income
(1)
Net income
(3)

Latest quarter · Q3 FY2019

Millions
Net income
(1)
Open Financials

Key stats

Open Analysis

Compound annual growth

Net income, 5 yearsFY2013 to FY2018
n/m

SAVICELL Corp financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Net income-$3.2 million-$2.1 million10-K 2019-04-03 · proof
Cash from operating activities-$1.3 million-$1 million10-K 2019-04-03 · proof
Total assets$238,312$325,880-26.9%10-K 2019-04-03 · proof
Total liabilities$3 million$1.9 million+57.3%10-K 2019-04-03 · proof
Cash and cash equivalents$120,245$232,247-48.2%10-K 2019-04-03 · proof
What was SAVICELL Corp's net income in fiscal 2018?
SAVICELL Corp reported net income of -$3.2 million for fiscal 2018 (the year ended Dec 31, 2018), against -$2.1 million the year before. Source: the 10-K filed with the SEC on Apr 3, 2019. SEC
What was SAVICELL Corp's cash from operating activities in fiscal 2018?
SAVICELL Corp reported cash from operating activities of -$1.3 million for fiscal 2018 (the year ended Dec 31, 2018), against -$1 million the year before. Source: the 10-K filed with the SEC on Apr 3, 2019. SEC
What are SAVICELL Corp's total assets?
As of Dec 31, 2018, SAVICELL Corp reported total assets of $238,312, against $325,880 a year earlier (-26.9%). Source: the 10-K filed with the SEC on Apr 3, 2019. SEC
What are SAVICELL Corp's total liabilities?
As of Dec 31, 2018, SAVICELL Corp reported total liabilities of $3 million, against $1.9 million a year earlier (+57.3%). Source: the 10-K filed with the SEC on Apr 3, 2019. SEC
What are SAVICELL Corp's cash and cash equivalents?
As of Dec 31, 2018, SAVICELL Corp reported cash and cash equivalents of $120,245, against $232,247 a year earlier (-48.2%). Source: the 10-K filed with the SEC on Apr 3, 2019. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1498380&period_type=annual&limit=5"

Information only, not investment advice.